Ovid Therapeutics Ownership 2024 | Who Owns Ovid Therapeutics Now?
Institutional Ownership
54.43%
Insider Ownership
15.87%
Retail Ownership
29.70%
Institutional Holders
74.00
Ovid Therapeutics Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| RUBRIC CAPITAL MANAGEMENT LP | 7.52% | 0.11% | 5,315,969 | - | - | 4,089,043 | Jun 30, 2024 |
| MADISON AVENUE PARTNERS, LP | 5.77% | 0.40% | 4,082,100 | 433,591 | 11.88% | 3,139,951 | Jun 30, 2024 |
| BLACKROCK INC. | 5.65% | 0.00% | 3,992,346 | -202,943 | -4.84% | 3,070,913 | Jun 30, 2024 |
| BVF INC/IL | 5.45% | 0.08% | 3,853,818 | - | - | 2,964,357 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.37% | - | 3,089,393 | 113,085 | 3.80% | 2,376,361 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 3.54% | 0.05% | 2,500,000 | - | - | 1,923,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.35% | 0.00% | 1,664,552 | 8,681 | 0.52% | 1,279,000 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 2.10% | 0.02% | 1,488,571 | 1,488,571 | 100.00% | 1,145,009 | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.07% | 0.00% | 1,466,433 | -111,628 | -7.07% | 1,127,980 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.98% | 0.01% | 1,400,191 | 1,400,191 | 100.00% | 1,077,027 | Jun 30, 2024 |
| STATE STREET CORP | 1.92% | - | 1,354,371 | 198,724 | 17.20% | 1,041,782,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.84% | 0.00% | 1,302,514 | 42,435 | 3.37% | 1,002,007 | Jun 30, 2024 |
| TLS ADVISORS LLC | 1.59% | 2.17% | 1,125,296 | -194,383 | -14.73% | 866,000 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 1.52% | 0.25% | 1,075,000 | 91,800 | 9.34% | 826,890 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 1.05% | 0.00% | 741,640 | 307,768 | 70.94% | 570,469 | Jun 30, 2024 |
| FFT WEALTH MANAGEMENT LLC | 0.69% | 0.03% | 489,552 | 75,530 | 18.24% | 376,563 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.66% | 0.00% | 465,532 | -15,335 | -3.19% | 358,087,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.50% | 0.01% | 352,170 | -5,700 | -1.59% | 270,889 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.41% | 0.01% | 288,290 | 28,790 | 11.09% | 221,695 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.39% | 0.00% | 274,982 | -67,187 | -19.64% | 211,372 | Jun 30, 2024 |
Ovid Therapeutics's largest institutional shareholder is RUBRIC CAPITAL MANAGEMENT LP, holding 7.52% of the company's total share outstanding, currently valued at $4.09M. The top 10 institutional shareholders own together 40.80% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| TLS ADVISORS LLC | 1.59% | 2.17% | 1,125,296 | -194,383 | -14.73% | 866,000 | Jun 30, 2024 |
| MADISON AVENUE PARTNERS, LP | 5.77% | 0.40% | 4,082,100 | 433,591 | 11.88% | 3,139,951 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 1.52% | 0.25% | 1,075,000 | 91,800 | 9.34% | 826,890 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 7.52% | 0.11% | 5,315,969 | - | - | 4,089,043 | Jun 30, 2024 |
| BVF INC/IL | 5.45% | 0.08% | 3,853,818 | - | - | 2,964,357 | Jun 30, 2024 |
| ARTAL GROUP S.A. | 3.54% | 0.05% | 2,500,000 | - | - | 1,923,000 | Jun 30, 2024 |
| FFT WEALTH MANAGEMENT LLC | 0.69% | 0.03% | 489,552 | 75,530 | 18.24% | 376,563 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 2.10% | 0.02% | 1,488,571 | 1,488,571 | 100.00% | 1,145,009 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 0.10% | 0.02% | 68,517 | -4,636 | -6.34% | 52,703 | Jun 30, 2024 |
| DCF ADVISERS, LLC | 0.06% | 0.02% | 41,750 | 22,020 | 111.61% | 32,114 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.41% | 0.01% | 288,290 | 28,790 | 11.09% | 221,695 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.98% | 0.01% | 1,400,191 | 1,400,191 | 100.00% | 1,077,027 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.17% | 0.01% | 119,507 | 119,507 | 100.00% | 92,000 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.50% | 0.01% | 352,170 | -5,700 | -1.59% | 270,889 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.03% | 0.01% | 20,000 | 20,000 | 100.00% | 15,000 | Jun 30, 2024 |
| ACADIAN ASSET MANAGEMENT LLC | 2.35% | 0.00% | 1,664,552 | 8,681 | 0.52% | 1,279,000 | Jun 30, 2024 |
| ADAR1 CAPITAL MANAGEMENT, LLC | 0.03% | 0.00% | 19,190 | 2,744 | 16.68% | 14,761 | Jun 30, 2024 |
| EMPOWERED FUNDS, LLC | 0.20% | 0.00% | 137,970 | 9,900 | 7.73% | 106,127 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 26,154 | 26,154 | 100.00% | 20,118 | Jun 30, 2024 |
| CHINA UNIVERSAL ASSET MANAGEMENT CO., LTD. | 0.01% | 0.00% | 8,335 | -5,244 | -38.62% | 6,411 | Jun 30, 2024 |
The largest Ovid Therapeutics shareholder by % of total assets is TLS ADVISORS LLC. The company owns 1.13M shares of Ovid Therapeutics (OVID), representing 2.17% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KENNEDY CAPITAL MANAGEMENT LLC | 2.10% | 0.02% | 1,488,571 | 1,488,571 | 100.00% | 1,145,009 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.98% | 0.01% | 1,400,191 | 1,400,191 | 100.00% | 1,077,027 | Jun 30, 2024 |
| MADISON AVENUE PARTNERS, LP | 5.77% | 0.40% | 4,082,100 | 433,591 | 11.88% | 3,139,951 | Jun 30, 2024 |
| WELLS FARGO & COMPANY/MN | 1.05% | 0.00% | 741,640 | 307,768 | 70.94% | 570,469 | Jun 30, 2024 |
| STATE STREET CORP | 1.92% | - | 1,354,371 | 198,724 | 17.20% | 1,041,782,000 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.17% | 0.01% | 119,507 | 119,507 | 100.00% | 92,000 | Jun 30, 2024 |
| VANGUARD GROUP INC | 4.37% | - | 3,089,393 | 113,085 | 3.80% | 2,376,361 | Jun 30, 2024 |
| PROSIGHT MANAGEMENT, LP | 1.52% | 0.25% | 1,075,000 | 91,800 | 9.34% | 826,890 | Jun 30, 2024 |
| DEUTSCHE BANK AG\ | 0.15% | - | 105,177 | 81,196 | 338.58% | 80,986 | Jun 30, 2024 |
| FFT WEALTH MANAGEMENT LLC | 0.69% | 0.03% | 489,552 | 75,530 | 18.24% | 376,563 | Jun 30, 2024 |
| GOLDMAN SACHS GROUP INC | 0.18% | - | 126,826 | 67,842 | 115.02% | 97,555 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.07% | - | 47,880 | 47,880 | 100.00% | 36,829 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.84% | 0.00% | 1,302,514 | 42,435 | 3.37% | 1,002,007 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 31,683 | 31,683 | 100.00% | 24,371 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 30,913 | 30,913 | 100.00% | 23,778 | Jun 30, 2024 |
| UBS OCONNOR LLC | 0.41% | 0.01% | 288,290 | 28,790 | 11.09% | 221,695 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 26,154 | 26,154 | 100.00% | 20,118 | Jun 30, 2024 |
| DCF ADVISERS, LLC | 0.06% | 0.02% | 41,750 | 22,020 | 111.61% | 32,114 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.03% | 0.01% | 20,000 | 20,000 | 100.00% | 15,000 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.02% | 0.00% | 13,282 | 13,282 | 100.00% | 8,320 | Jun 30, 2024 |
As of Jun 30 2024, Ovid Therapeutics's largest institutional buyer is KENNEDY CAPITAL MANAGEMENT LLC. The company purchased 1.49M stocks of OVID, valued at $1.15M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -6,117,400 | -100.00% | - | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | - | - | - | -864,822 | -100.00% | - | Jun 30, 2024 |
| BLACKROCK INC. | 5.65% | 0.00% | 3,992,346 | -202,943 | -4.84% | 3,070,913 | Jun 30, 2024 |
| TLS ADVISORS LLC | 1.59% | 2.17% | 1,125,296 | -194,383 | -14.73% | 866,000 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | - | - | - | -114,265 | -100.00% | - | Jun 30, 2024 |
| JPMORGAN CHASE & CO | 2.07% | 0.00% | 1,466,433 | -111,628 | -7.07% | 1,127,980 | Jun 30, 2024 |
| WELLINGTON MANAGEMENT GROUP LLP | 0.16% | - | 115,832 | -107,061 | -48.03% | 89,098 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -84,233 | -100.00% | - | Jun 30, 2024 |
| FMR LLC | 0.00% | - | 2,502 | -83,705 | -97.10% | 1,925 | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -71,264 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -68,343 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.11% | - | 78,024 | -67,941 | -46.55% | 60,016 | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.39% | 0.00% | 274,982 | -67,187 | -19.64% | 211,372 | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -62,341 | -100.00% | - | Jun 30, 2024 |
| UBS GROUP AG | 0.03% | - | 21,192 | -52,230 | -71.14% | 16,297 | Jun 30, 2024 |
| BANK OF NOVA SCOTIA | - | - | - | -44,152 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -35,938 | -100.00% | - | Jun 30, 2024 |
| MORGAN STANLEY | 0.10% | - | 68,950 | -31,003 | -31.02% | 53,035 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -29,386 | -100.00% | - | Jun 30, 2024 |
| TWO SIGMA INVESTMENTS, LP | 0.02% | - | 12,628 | -28,041 | -68.95% | 9,713 | Jun 30, 2024 |
As of Jun 30 2024, Ovid Therapeutics's biggest institutional seller is ECOR1 CAPITAL, LLC. The company sold -6.12M shares of OVID, valued at -.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KENNEDY CAPITAL MANAGEMENT LLC | 2.10% | 0.02% | 1,488,571 | 1,488,571 | 100.00% | 1,145,009 | Jun 30, 2024 |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1.98% | 0.01% | 1,400,191 | 1,400,191 | 100.00% | 1,077,027 | Jun 30, 2024 |
| GSA CAPITAL PARTNERS LLP | 0.17% | 0.01% | 119,507 | 119,507 | 100.00% | 92,000 | Jun 30, 2024 |
| ALLIANCEBERNSTEIN L.P. | 0.07% | - | 47,880 | 47,880 | 100.00% | 36,829 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 31,683 | 31,683 | 100.00% | 24,371 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 30,913 | 30,913 | 100.00% | 23,778 | Jun 30, 2024 |
| XTX TOPCO LTD | 0.04% | 0.00% | 26,154 | 26,154 | 100.00% | 20,118 | Jun 30, 2024 |
| KNOTT DAVID M JR | 0.03% | 0.01% | 20,000 | 20,000 | 100.00% | 15,000 | Jun 30, 2024 |
| BAADER BANK AKTIENGESELLSCHAFT | 0.02% | 0.00% | 13,282 | 13,282 | 100.00% | 8,320 | Jun 30, 2024 |
| BBR PARTNERS, LLC | 0.02% | 0.00% | 12,495 | 12,495 | 100.00% | 9,611 | Jun 30, 2024 |
| FEDERATED HERMES, INC. | 0.00% | - | 2,250 | 2,250 | 100.00% | 1,731,000 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 1,598 | 1,598 | 100.00% | 1,229 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 143 | 143 | 100.00% | 110 | Jun 30, 2024 |
Ovid Therapeutics's largest new institutional shareholder by number of shares is KENNEDY CAPITAL MANAGEMENT LLC, purchased 1.49M shares, valued at $1.15M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | - | - | - | -6,117,400 | -100.00% | - | Jun 30, 2024 |
| BLUE OWL CAPITAL HOLDINGS LP | - | - | - | -864,822 | -100.00% | - | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | - | - | - | -114,265 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -84,233 | -100.00% | - | Jun 30, 2024 |
| D. E. SHAW & CO., INC. | - | - | - | -71,264 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | - | - | - | -68,343 | -100.00% | - | Jun 30, 2024 |
| JACOBS LEVY EQUITY MANAGEMENT, INC | - | - | - | -62,341 | -100.00% | - | Jun 30, 2024 |
| BANK OF NOVA SCOTIA | - | - | - | -44,152 | -100.00% | - | Jun 30, 2024 |
| SG AMERICAS SECURITIES, LLC | - | - | - | -35,938 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -29,386 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -25,980 | -100.00% | - | Jun 30, 2024 |
| PRELUDE CAPITAL MANAGEMENT, LLC | - | - | - | -25,555 | -100.00% | - | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | - | - | - | -22,819 | -100.00% | - | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | - | - | - | -16,796 | -100.00% | - | Jun 30, 2024 |
| OCCUDO QUANTITATIVE STRATEGIES LP | - | - | - | -14,086 | -100.00% | - | Jun 30, 2024 |
| BAILARD, INC. | - | - | - | -12,600 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -977 | -100.00% | - | Jun 30, 2024 |
| ICA GROUP WEALTH MANAGEMENT, LLC | - | - | - | -55 | -100.00% | - | Jun 30, 2024 |
| QUBE RESEARCH & TECHNOLOGIES LTD | - | - | - | -54 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -10 | -100.00% | - | Jun 30, 2024 |
Ovid Therapeutics's largest sold out institutional shareholder by shares sold is ECOR1 CAPITAL, LLC, sold -6.12M shares, valued at -, as of undefined.
Ovid Therapeutics Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| TEKLA HEALTHCARE INVESTORS | 0.30% | 260,913 | - | - | Mar 31, 2024 |
| STATE STREET INSTITUTIONAL FUNDS | 0.30% | 237,842 | - | - | Mar 31, 2024 |
| TEKLA LIFE SCIENCES INVESTORS | 0.24% | 111,820 | - | - | Mar 31, 2024 |
| BRIDGEWAY FUNDS INC | 0.09% | 218,400 | -91,100 | -29.43% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.08% | 43,087 | - | - | Mar 31, 2024 |
| VANGUARD EXPLORER FUND | 0.08% | 940,320 | - | - | Jan 31, 2024 |
| Vericimetry Funds | 0.05% | 4,110 | - | - | Mar 31, 2024 |
| ETFis Series Trust I | 0.04% | 55,764 | - | - | Jan 31, 2024 |
| Lattice Strategies Trust | 0.02% | 35,945 | - | - | Mar 31, 2024 |
| TIAA SEPARATE ACCOUNT VA 1 | 0.02% | 5,028 | 2,187 | 76.98% | Mar 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.02% | 108,595 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.02% | 9,195 | - | - | Mar 31, 2024 |
| FIDELITY SELECT PORTFOLIOS | 0.01% | 626,163 | - | - | Feb 29, 2024 |
| Fidelity Commonwealth Trust II | 0.01% | 59,108 | - | - | Aug 31, 2023 |
| FIDELITY COMMONWEALTH TRUST | 0.01% | 27,246 | - | - | Feb 29, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.01% | 80,907 | - | - | Mar 31, 2024 |
| INVESCO EXCHANGE-TRADED FUND TRUST | 0.01% | 662,418 | - | - | Jan 31, 2024 |
| VANGUARD INDEX FUNDS | 0.01% | 2,581,909 | -782,035 | -23.25% | Mar 31, 2024 |
| Legg Mason ETF Investment Trust | 0.01% | 11,811 | - | - | Mar 31, 2024 |
| VANGUARD QUANTITATIVE FUNDS | 0.01% | 24,500 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 161,808 | -8,228 | -4.84% | Jan 31, 2024 |
| VANGUARD VARIABLE INSURANCE FUNDS | 0.00% | 193,033 | - | - | Mar 31, 2024 |
| VARIABLE INSURANCE PRODUCTS FUND II | 0.00% | 41,092 | - | - | Mar 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 547,178 | 13,667 | 2.56% | Feb 29, 2024 |
| Voya INVESTORS TRUST | 0.00% | 135,407 | -10,036 | -6.90% | Mar 31, 2024 |
| FIDELITY COVINGTON TRUST | 0.00% | 43,604 | -504 | -1.14% | Mar 31, 2024 |
| SEASONS SERIES TRUST | 0.00% | 45,136 | -2,508 | -5.26% | Mar 31, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 4,924 | - | - | Mar 31, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 37,897 | -2,736 | -6.73% | Mar 31, 2024 |
| Principal Exchange-Traded Funds | 0.00% | 12,598 | - | - | Mar 31, 2024 |
| Global X Funds | 0.00% | 32,231 | - | - | Jan 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 22,819 | -3,978 | -14.84% | Mar 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 3,406 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 353 | - | - | Apr 30, 2021 |
| TIAA-CREF LIFE FUNDS | 0.00% | 1,735 | - | - | Mar 31, 2024 |
| JPMorgan Trust I | 0.00% | 617,094 | - | - | Jan 31, 2024 |
| GPS Funds I | 0.00% | 2,749 | - | - | Mar 31, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 119,346 | - | - | Jan 31, 2024 |
| AdvisorShares Trust | 0.00% | 1,336 | - | - | Mar 28, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 18,300 | - | - | Mar 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 22,384 | -867 | -3.73% | Feb 29, 2024 |
| NORTHERN FUNDS | 0.00% | 27,751 | 3,623 | 15.02% | Mar 28, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 21,212 | - | - | Mar 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 3,876 | 510 | 15.15% | Mar 31, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 22,495 | 300 | 1.35% | Jan 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 174,252 | 95,763 | 122.01% | Jan 31, 2024 |
| iSHARES TRUST | 0.00% | 2,522,818 | -118,586 | -4.49% | Mar 31, 2024 |
| PGIM ETF TRUST | 0.00% | 9,327 | - | - | Feb 29, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 264,047 | 29,347 | 12.50% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 544 | - | - | Dec 31, 2023 |
| HC CAPITAL TRUST | 0.00% | 4,105 | - | - | Mar 31, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 6,294 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 109,325 | 18 | 0.02% | Mar 31, 2024 |
| VALIC Co I | 0.00% | 22,883 | -93 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 2,300 | - | - | Mar 28, 2024 |
| AMERICAN CENTURY ETF TRUST | 0.00% | 8,931 | 20 | 0.22% | Feb 29, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 30,304 | - | - | Feb 29, 2024 |
| ETF Series Solutions | 0.00% | 1,555 | - | - | Jan 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 22,862 | - | - | Jan 31, 2024 |
| WisdomTree Trust | 0.00% | 140,387 | - | - | Feb 29, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 270 | - | - | Dec 31, 2023 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 162,929 | -10,642 | -6.13% | Mar 31, 2024 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 8,507 | - | - | Mar 31, 2024 |
| PROSHARES TRUST | 0.00% | 14,015 | 6,311 | 81.92% | Feb 29, 2024 |
| Dimensional ETF Trust | 0.00% | 22,828 | 6,081 | 36.31% | Jan 31, 2024 |
| Federated Hermes Global Allocation Fund | 0.00% | 483 | - | - | Feb 29, 2024 |
| ProFunds | 0.00% | 463 | -38 | -7.58% | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 7,805 | 1,370 | 21.29% | Jan 31, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 36 | - | - | Dec 31, 2023 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 29,936 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 82,414 | - | - | Jan 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 2,010 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 6,756 | -27 | -0.40% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 1,088 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 25,821 | 1,130 | 4.58% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 43,834 | -1,362 | -3.01% | Mar 31, 2024 |
| WILSHIRE MUTUAL FUNDS INC | 0.00% | 2,500 | - | - | Dec 31, 2023 |
| Invesco Exchange-Traded Fund Trust II | 0.00% | 1,883 | 578 | 44.29% | Feb 29, 2024 |
| PACIFIC SELECT FUND | 0.00% | 22,273 | -605 | -2.64% | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 5,252 | -14,921 | -73.97% | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 5,833 | - | - | Dec 31, 2023 |
| Bridge Builder Trust | 0.00% | 25,732 | - | - | Mar 31, 2024 |
| SEI INSTITUTIONAL MANAGED TRUST | 0.00% | 11,074 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 12,686 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 6,988 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 7,521 | -1,253 | -14.28% | Jan 31, 2024 |
| John Hancock Funds II | 0.00% | 7,974 | - | - | Feb 29, 2024 |
| SEI INSTITUTIONAL INVESTMENTS TRUST | 0.00% | 10,200 | - | - | Feb 29, 2024 |
| Advisors' Inner Circle Fund III | 0.00% | 22 | - | - | Jan 31, 2024 |
Ovid Therapeutics's largest mutual fund holder by % of total assets is "TEKLA HEALTHCARE INVESTORS", owning 260.91K shares, compromising 0.30% of its total assets.
Ovid Therapeutics Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 74 | -8.64% |
| 31 Mar, 24 | 81 | 5.19% |
| 31 Dec, 23 | 77 | 20.31% |
| 30 Sep, 23 | 64 | -9.86% |
| 30 Jun, 23 | 71 | 14.52% |
| 31 Mar, 23 | 62 | 3.33% |
| 31 Dec, 22 | 60 | 3.45% |
| 30 Sep, 22 | 58 | 3.57% |
| 30 Jun, 22 | 56 | -11.11% |
| 31 Mar, 22 | 63 | -7.35% |
| 31 Dec, 21 | 68 | -9.33% |
| 30 Sep, 21 | 75 | -9.64% |
| 30 Jun, 21 | 83 | -8.79% |
| 31 Mar, 21 | 91 | 8.33% |
| 31 Dec, 20 | 84 | -12.50% |
| 30 Sep, 20 | 96 | 15.66% |
| 30 Jun, 20 | 83 | 48.21% |
| 31 Mar, 20 | 56 | -8.20% |
| 31 Dec, 19 | 61 | 64.86% |
| 30 Sep, 19 | 37 | 12.12% |
| 30 Jun, 19 | 33 | -32.65% |
| 31 Mar, 19 | 49 | 6.52% |
| 31 Dec, 18 | 46 | -6.12% |
| 30 Sep, 18 | 49 | 2.08% |
| 30 Jun, 18 | 48 | - |
| 31 Mar, 18 | 48 | -2.04% |
| 31 Dec, 17 | 49 | 16.67% |
| 30 Sep, 17 | 42 | -2.33% |
| 30 Jun, 17 | 43 | - |
As of 30 Jun 24, 74 institutions are holding Ovid Therapeutics's shares, representing a decrease of -8.64% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 38,492,740 | -9.60% |
| 31 Mar, 24 | 42,579,420 | -3.51% |
| 31 Dec, 23 | 44,126,877 | 4.21% |
| 30 Sep, 23 | 42,343,665 | 3.26% |
| 30 Jun, 23 | 41,007,449 | 5.98% |
| 31 Mar, 23 | 38,694,424 | 0.35% |
| 31 Dec, 22 | 38,559,968 | 8.34% |
| 30 Sep, 22 | 35,592,877 | 2.65% |
| 30 Jun, 22 | 34,672,949 | -1.30% |
| 31 Mar, 22 | 35,130,156 | 3.28% |
| 31 Dec, 21 | 34,014,842 | 1.18% |
| 30 Sep, 21 | 33,618,146 | 0.69% |
| 30 Jun, 21 | 33,386,988 | -7.90% |
| 31 Mar, 21 | 36,251,784 | 31.40% |
| 31 Dec, 20 | 27,589,430 | 9.94% |
| 30 Sep, 20 | 25,096,118 | 14.95% |
| 30 Jun, 20 | 21,831,948 | 37.73% |
| 31 Mar, 20 | 15,850,964 | -10.70% |
| 31 Dec, 19 | 17,750,192 | 116.75% |
| 30 Sep, 19 | 8,189,312 | -19.09% |
| 30 Jun, 19 | 10,121,863 | -17.56% |
| 31 Mar, 19 | 12,277,688 | 79.61% |
| 31 Dec, 18 | 6,835,929 | -7.54% |
| 30 Sep, 18 | 7,393,368 | -3.40% |
| 30 Jun, 18 | 7,653,405 | 8.58% |
| 31 Mar, 18 | 7,048,820 | -9.89% |
| 31 Dec, 17 | 7,822,642 | 8.32% |
| 30 Sep, 17 | 7,221,955 | -9.63% |
| 30 Jun, 17 | 7,991,459 | - |
Ovid Therapeutics (OVID) has 38.49M shares outstanding as of 30 Jun 24, down -9.60% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 54.43% | 1.50% |
| 31 Mar, 24 | 60.33% | 1.55% |
| 31 Dec, 23 | 62.49% | 1.73% |
| 30 Sep, 23 | 60.03% | 1.77% |
| 30 Jun, 23 | 58.17% | 1.93% |
| 31 Mar, 23 | 54.89% | 1.83% |
| 31 Dec, 22 | 54.75% | 2.14% |
| 30 Sep, 22 | 50.54% | 2.08% |
| 30 Jun, 22 | 49.26% | 1.98% |
| 31 Mar, 22 | 49.94% | 1.97% |
| 31 Dec, 21 | 50.41% | 2.06% |
| 30 Sep, 21 | 49.49% | 2.04% |
| 30 Jun, 21 | 49.23% | 1.64% |
| 31 Mar, 21 | 54.85% | 2.95% |
| 31 Dec, 20 | 43.11% | 2.42% |
| 30 Sep, 20 | 42.24% | 2.74% |
| 30 Jun, 20 | 39.26% | 4.68% |
| 31 Mar, 20 | 28.97% | 2.22% |
| 31 Dec, 19 | 36.12% | 7.99% |
| 30 Sep, 19 | 21.27% | 3.11% |
| 30 Jun, 19 | 26.16% | 1.60% |
| 31 Mar, 19 | 40.48% | 5.26% |
| 31 Dec, 18 | 27.75% | 3.08% |
| 30 Sep, 18 | 30.01% | 3.11% |
| 30 Jun, 18 | 31.08% | 3.79% |
| 31 Mar, 18 | 28.64% | 2.83% |
| 31 Dec, 17 | 31.79% | 3.69% |
| 30 Sep, 17 | 29.36% | 1.51% |
| 30 Jun, 17 | 44.12% | - |
As of 30 Jun 24, Ovid Therapeutics is held by 54.43% institutional shareholders, representing a 1.50% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 36 | -5.26% |
| 31 Mar, 24 | 38 | -7.32% |
| 31 Dec, 23 | 41 | 78.26% |
| 30 Sep, 23 | 23 | -48.89% |
| 30 Jun, 23 | 45 | 87.50% |
| 31 Mar, 23 | 24 | 20.00% |
| 31 Dec, 22 | 20 | -25.93% |
| 30 Sep, 22 | 27 | 42.11% |
| 30 Jun, 22 | 19 | -32.14% |
| 31 Mar, 22 | 28 | 7.69% |
| 31 Dec, 21 | 26 | -13.33% |
| 30 Sep, 21 | 30 | -25.00% |
| 30 Jun, 21 | 40 | -16.67% |
| 31 Mar, 21 | 48 | -5.88% |
| 31 Dec, 20 | 51 | 10.87% |
| 30 Sep, 20 | 46 | -20.69% |
| 30 Jun, 20 | 58 | 107.14% |
| 31 Mar, 20 | 28 | -44.00% |
| 31 Dec, 19 | 50 | 163.16% |
| 30 Sep, 19 | 19 | 46.15% |
| 30 Jun, 19 | 13 | -59.38% |
| 31 Mar, 19 | 32 | 52.38% |
| 31 Dec, 18 | 21 | -25.00% |
| 30 Sep, 18 | 28 | -3.45% |
| 30 Jun, 18 | 29 | -17.14% |
| 31 Mar, 18 | 35 | 16.67% |
| 31 Dec, 17 | 30 | 66.67% |
| 30 Sep, 17 | 18 | -58.14% |
| 30 Jun, 17 | 43 | - |
36 institutional shareholders have increased their position in OVID stock as of 30 Jun 24 compared to 38 in the previous quarter (a -5.26% decrease).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 25 | 4.17% |
| 31 Mar, 24 | 24 | 41.18% |
| 31 Dec, 23 | 17 | -15.00% |
| 30 Sep, 23 | 20 | 42.86% |
| 30 Jun, 23 | 14 | -6.67% |
| 31 Mar, 23 | 15 | -28.57% |
| 31 Dec, 22 | 21 | 10.53% |
| 30 Sep, 22 | 19 | -26.92% |
| 30 Jun, 22 | 26 | 44.44% |
| 31 Mar, 22 | 18 | -18.18% |
| 31 Dec, 21 | 22 | -18.52% |
| 30 Sep, 21 | 27 | -6.90% |
| 30 Jun, 21 | 29 | 26.09% |
| 31 Mar, 21 | 23 | 53.33% |
| 31 Dec, 20 | 15 | -48.28% |
| 30 Sep, 20 | 29 | 70.59% |
| 30 Jun, 20 | 17 | -10.53% |
| 31 Mar, 20 | 19 | 280.00% |
| 31 Dec, 19 | 5 | -58.33% |
| 30 Sep, 19 | 12 | -14.29% |
| 30 Jun, 19 | 14 | 100.00% |
| 31 Mar, 19 | 7 | -56.25% |
| 31 Dec, 18 | 16 | 60.00% |
| 30 Sep, 18 | 10 | -9.09% |
| 30 Jun, 18 | 11 | 57.14% |
| 31 Mar, 18 | 7 | -30.00% |
| 31 Dec, 17 | 10 | -9.09% |
| 30 Sep, 17 | 11 | - |
| 30 Jun, 17 | - | - |
25 institutional shareholders have reduced their position in OVID stock as of 30 Jun 24 compared to 24 in the previous quarter (a 4.17% increase).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 74 | -8.64% | 38,492,740 | -9.60% | 54.43% | 1.50% | 36 | -5.26% | 25 | 4.17% |
| 31 Mar, 24 | 81 | 5.19% | 42,579,420 | -3.51% | 60.33% | 1.55% | 38 | -7.32% | 24 | 41.18% |
| 31 Dec, 23 | 77 | 20.31% | 44,126,877 | 4.21% | 62.49% | 1.73% | 41 | 78.26% | 17 | -15.00% |
| 30 Sep, 23 | 64 | -9.86% | 42,343,665 | 3.26% | 60.03% | 1.77% | 23 | -48.89% | 20 | 42.86% |
| 30 Jun, 23 | 71 | 14.52% | 41,007,449 | 5.98% | 58.17% | 1.93% | 45 | 87.50% | 14 | -6.67% |
| 31 Mar, 23 | 62 | 3.33% | 38,694,424 | 0.35% | 54.89% | 1.83% | 24 | 20.00% | 15 | -28.57% |
| 31 Dec, 22 | 60 | 3.45% | 38,559,968 | 8.34% | 54.75% | 2.14% | 20 | -25.93% | 21 | 10.53% |
| 30 Sep, 22 | 58 | 3.57% | 35,592,877 | 2.65% | 50.54% | 2.08% | 27 | 42.11% | 19 | -26.92% |
| 30 Jun, 22 | 56 | -11.11% | 34,672,949 | -1.30% | 49.26% | 1.98% | 19 | -32.14% | 26 | 44.44% |
| 31 Mar, 22 | 63 | -7.35% | 35,130,156 | 3.28% | 49.94% | 1.97% | 28 | 7.69% | 18 | -18.18% |
| 31 Dec, 21 | 68 | -9.33% | 34,014,842 | 1.18% | 50.41% | 2.06% | 26 | -13.33% | 22 | -18.52% |
| 30 Sep, 21 | 75 | -9.64% | 33,618,146 | 0.69% | 49.49% | 2.04% | 30 | -25.00% | 27 | -6.90% |
| 30 Jun, 21 | 83 | -8.79% | 33,386,988 | -7.90% | 49.23% | 1.64% | 40 | -16.67% | 29 | 26.09% |
| 31 Mar, 21 | 91 | 8.33% | 36,251,784 | 31.40% | 54.85% | 2.95% | 48 | -5.88% | 23 | 53.33% |
| 31 Dec, 20 | 84 | -12.50% | 27,589,430 | 9.94% | 43.11% | 2.42% | 51 | 10.87% | 15 | -48.28% |
| 30 Sep, 20 | 96 | 15.66% | 25,096,118 | 14.95% | 42.24% | 2.74% | 46 | -20.69% | 29 | 70.59% |
| 30 Jun, 20 | 83 | 48.21% | 21,831,948 | 37.73% | 39.26% | 4.68% | 58 | 107.14% | 17 | -10.53% |
| 31 Mar, 20 | 56 | -8.20% | 15,850,964 | -10.70% | 28.97% | 2.22% | 28 | -44.00% | 19 | 280.00% |
| 31 Dec, 19 | 61 | 64.86% | 17,750,192 | 116.75% | 36.12% | 7.99% | 50 | 163.16% | 5 | -58.33% |
| 30 Sep, 19 | 37 | 12.12% | 8,189,312 | -19.09% | 21.27% | 3.11% | 19 | 46.15% | 12 | -14.29% |
| 30 Jun, 19 | 33 | -32.65% | 10,121,863 | -17.56% | 26.16% | 1.60% | 13 | -59.38% | 14 | 100.00% |
| 31 Mar, 19 | 49 | 6.52% | 12,277,688 | 79.61% | 40.48% | 5.26% | 32 | 52.38% | 7 | -56.25% |
| 31 Dec, 18 | 46 | -6.12% | 6,835,929 | -7.54% | 27.75% | 3.08% | 21 | -25.00% | 16 | 60.00% |
| 30 Sep, 18 | 49 | 2.08% | 7,393,368 | -3.40% | 30.01% | 3.11% | 28 | -3.45% | 10 | -9.09% |
| 30 Jun, 18 | 48 | - | 7,653,405 | 8.58% | 31.08% | 3.79% | 29 | -17.14% | 11 | 57.14% |
| 31 Mar, 18 | 48 | -2.04% | 7,048,820 | -9.89% | 28.64% | 2.83% | 35 | 16.67% | 7 | -30.00% |
| 31 Dec, 17 | 49 | 16.67% | 7,822,642 | 8.32% | 31.79% | 3.69% | 30 | 66.67% | 10 | -9.09% |
| 30 Sep, 17 | 42 | -2.33% | 7,221,955 | -9.63% | 29.36% | 1.51% | 18 | -58.14% | 11 | - |
| 30 Jun, 17 | 43 | - | 7,991,459 | - | 44.12% | - | 43 | - | - | - |
Ovid Therapeutics Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of Ovid Therapeutics's stock was made by LEVIN JEREMY M on Feb 14 2024, selling 465,116 shares at - per share (valued at -). The last insider buy of OVID was made by LEVIN JEREMY M on Mar 20 2024, buying 18,248 shares at $2.76 per share (worth $50.36K).
Ovid Therapeutics Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 1 | - | - |
| Q1 2024 | 13 | - | - |
| Q4 2023 | - | 2 | - |
| Q1 2023 | 9 | - | - |
| Q3 2022 | 4 | 3 | 133.33% |
| Q2 2022 | 13 | - | - |
| Q1 2022 | 9 | - | - |
| Q4 2021 | 1 | - | - |
| Q3 2021 | 4 | 1 | 400.00% |
| Q2 2021 | 8 | - | - |
| Q1 2021 | 1 | - | - |
| Q4 2020 | 12 | - | - |
| Q3 2020 | 2 | - | - |
| Q2 2020 | 5 | - | - |
| Q1 2020 | 1 | - | - |
| Q4 2019 | 14 | - | - |
| Q3 2019 | - | 1 | - |
| Q2 2019 | 10 | - | - |
| Q1 2019 | 8 | 1 | 800.00% |
| Q3 2018 | 6 | - | - |
1 total buy trades, and 0 total sell trades (buy/sell ratio of 0%) were made by Ovid Therapeutics's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | - | - | - |
| Q1 2024 | 1 | - | - |
| Q4 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q3 2022 | - | 1 | - |
| Q2 2022 | - | - | - |
| Q1 2022 | - | - | - |
| Q4 2021 | - | - | - |
| Q3 2021 | - | 1 | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | - | - |
| Q4 2020 | - | - | - |
| Q3 2020 | 1 | - | - |
| Q2 2020 | - | - | - |
| Q1 2020 | - | - | - |
| Q4 2019 | 2 | - | - |
| Q3 2019 | - | - | - |
| Q2 2019 | - | - | - |
| Q1 2019 | 2 | - | - |
| Q3 2018 | 2 | - | - |
As of Q3 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Ovid Therapeutics's stocks.
OVID Ownership FAQ
Who Owns Ovid Therapeutics?
Ovid Therapeutics is owned by institutional shareholders (54.43%), insiders (15.87%), and public (29.70%). The largest institutional shareholder of Ovid Therapeutics is RUBRIC CAPITAL MANAGEMENT LP (7.52% of total shares) and the top mutual fund owner is TEKLA HEALTHCARE INVESTORS (0.30% of total shares).
Who are the major institutional shareholders of Ovid Therapeutics?
Ovid Therapeutics's major institutional shareholders are RUBRIC CAPITAL MANAGEMENT LP, MADISON AVENUE PARTNERS, LP, BLACKROCK INC., BVF INC/IL, and VANGUARD GROUP INC. The top five shareholders own together 28.75% of the company's share outstanding.
How many Ovid Therapeutics shareholders are there?
As of Jun 2024, there are 74 institutional shareholders of Ovid Therapeutics.
What percentage of Ovid Therapeutics is owned by RUBRIC CAPITAL MANAGEMENT LP?
RUBRIC CAPITAL MANAGEMENT LP owns 5.32M shares of Ovid Therapeutics, representing 7.52% of the company's total shares outstanding, valued at $4.09M (as of Jun 2024).
What percentage of Ovid Therapeutics is owned by MADISON AVENUE PARTNERS, LP?
As of Jun 2024, MADISON AVENUE PARTNERS, LP holds 4.08M shares of Ovid Therapeutics (OVID), compromising 5.77% of the company, valued at $3.14M.
What percentage of Ovid Therapeutics is owned by BLACKROCK INC?
BLACKROCK INC is the third largest holder of Ovid Therapeutics. The company owns 3.99M of the company's shares outstanding (worth $3.07M).